ARTICLE | Deals
Sanofi adds to COVID-19 pipeline with Translate deal
BioCentury is providing this story for free given the urgent need for information about the COVID-19 crisis. For more analysis, sign up for our daily email.
March 28, 2020 12:13 AM UTC
Updated on Mar 28, 2020 at 1:37 AM UTC
A partnership with Translate Bio to develop an mRNA-based vaccine is one of multiple shots on goal Sanofi is preparing against COVID-19.
The collaboration is part of a 2018 deal in which Sanofi (Euronext:SAN; NASDAQ:SNY) is using the mRNA platform from Translate Bio Inc. (NASDAQ:TBIO) to develop vaccines for up to five infectious diseases...